Trial intelligence / Profile preview

Prothrombin Complex Concentrate in Hemophilia B

CTR20181716Phase 3Completed

Sponsor
Hualan Biological Engineering Chongqing
Start
Sep 2018
Modality
Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of balfaxar in hemophilia B (HB), sponsored by Hualan Biological Engineering Chongqing. Started Sep 2018; status: completed.

02

Drugs

balfaxar
03

Conditions

hemophilia B (HB)

Beyond the preview

Go deeper on CTR20181716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20181716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call